Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.
Press releases published on September 8, 2025
Victra Earns 2025 Great Place To Work Certification™
RALEIGH, NC, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Victra is proud to be Certified™ by Great Place To Work® for the first time! The prestigious award is based entirely on what current employees say about their experience working at …
Voxtur Announces Cease Trade Order and Notice of Default
TORONTO and TAMPA, Fla., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today …
Resilience: The Compass for Thriving in Challenging Times
Ground-breaking framework helps leaders, teams, and individuals reset, rise stronger, and thrive amid today’s rising stress and uncertainty. RALEIGH, NC, UNITED STATES, September 8, 2025 /EINPresswire.com/ -- Stress and burnout in the United States have …
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the pricing of its private offering (the “Offering”) of $250.0 million aggregate …
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
New York, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- LEA, a company providing client data automation for wealth management, today announced $1.25 million in funding led by Social Leverage, with prior participation from experienced RIA and institutional wealth …
Diginex Announces Completion of Eight to One Stock Split Paid as Bonus Shares
LONDON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, today announced that it has completed the distribution of the bonus shares issuance, whereby 7 bonus ordinary …
Kleen HY-DRO-GEN INC. Announces Commencement of Trading
Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Kleen HY-DRO-GEN Inc. (formerly 0755461 B.C. Ltd.) (the "Resulting Issuer") is pleased to announce that following …
Computer Resources of America Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
New York, NY , Sept. 08, 2025 (GLOBE NEWSWIRE) -- Computer Resources of America (CRA), a leading provider of innovative IT solutions and managed services, is proud to announce its inclusion in the prestigious 2025 Inc. 5000 list, recognizing the fastest- …
DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors
NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research …
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug …
House of Doge Treasury Partner CleanCore Solutions Acquires 285,420,000 DOGE with Strategic Goal to Accumulate First Milestone Target of 1 Billion DOGE in 30 Days as the Newly Launched Official Dogecoin Treasury
MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, together with their partner CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or “ZONE”), announced the successful acquisition of 285 …
PharmAla Completes Import of LaNeo MDMA for US Distribution
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that …
CompoSecure to Move Stock Exchange Listing to NYSE
SOMERSET, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO) (“CompoSecure” or the “Company”) today announced that it will transfer the listing of its Class A common stock (Nasdaq: CMPO) to the New York Stock Exchange (“NYSE”) from …
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are further supported by early data from open- …
Rapport Announces Proposed Public Offering of Common Stock
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Abivax Presents First Half 2025 Financial Results
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …